event information
Thursday, 1 September 2022
8:30am - 9:30am AEST
Live session through Microsoft Teams
- More
Medical cannabis continues to challenge both scientific norms and the regulator. It’s use in medicine is seen as controversial by many medical practitioners.
Evidence around the efficacy of cannabis for certain health conditions continues to evolve with a rapidly increasing number of randomised control trials and preclinical research.
But the fact is that medical cannabis has been recognised in Australia as having therapeutic qualities since February 2016. Its availability varies by location and the rules vary from State to State.
In our next FTC session Rob Samut will discuss the medical cannabis journey in Australia, how it is regulated and mull over some of the legal liability risks faced by those who prescribe it.